AMED Financial Facts

Other: 42.66M
Operating expenses: 347.24M
See Full Income Statement

Total Amedisys, Inc. stockholders' equity: 445.45M
Accumulated other comprehensive income: 15K
See Full Balance Sheet

Amedisys (AMED) Earnings

  |   Expand Research on AMED
Next EPS Date 8/4/22 *Est. EPS Growth Rate -18.0% *Last Qtr.
Average EPS % Beat Rate -22.2% Revenue Growth Rate +1.5% *Last Qtr.
Average % Move 1-Wk after EPS -1.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/27/22 Q122 $1.23$1.12 +$0.11$545.3M$558.84M = Details
2/23/22 Q421 $1.18$1.18 $0.00$559.3M$555.2M = Details
11/2/21 Q321 $0.00$1.37 -$1.37N/A$568.37M = Details
8/4/21 Q221 $1.69$1.67 +$0.02$564.2M$566.19M = Details
4/28/21 Q121 $1.50$1.43 +$0.07$537.14M$544.86M = Details
2/24/21 Q420 $1.49$1.47 +$0.02$550.71M$553.37M = Details
10/28/20 Q320 $2.24$1.28 +$0.96$544.1M$533.18M = Details
7/28/20 Q220 $1.34$0.81 +$0.53$485M$469.13M = Details